Results 141 to 150 of about 18,493 (204)

Banning new gas boilers as a no-regret mitigation option. [PDF]

Nat Commun
Escribe C, Vivier L.
europepmc   +1 more source

The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD. [PDF]

Kidney Med, 2022
Perrone RD, Hariri A, Minini P, Ahn C, Chapman AB, Horie S, Knebelmann B, Mrug M, Ong ACM, Pei YPC, Torres VE, Modur V, Gansevoort RT.   +12 more
europepmc   +1 more source

Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells. [PDF]

Int J Mol Sci, 2019
Di Mise A, Venneri M, Ranieri M, Centrone M, Pellegrini L, Tamma G, Valenti G.   +6 more
europepmc   +1 more source

Asymptomatic Pyuria as a Prognostic Biomarker in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Kidney360, 2022
Jones BE, Mkhaimer YG, Rangel LJ, Chedid M, Schulte PJ, Mohamed AK, Neal RM, Zubidat D, Randhawa AK, Hanna C, Gregory AV, Kline TL, Zoghby ZM, Senum SR, Harris PC, Torres VE, Chebib FT.   +16 more
europepmc   +1 more source

The Palladio Method

The architect Andrea Palladio was a draughtsman and a designer, a mason and an engineer, an innovator and an image maker. His growing importance from the 16th century onwards was based on his profound expertise in architectural issues that went beyond singular tasks and situations, and beyond his particular moment in history.
openaire   +1 more source

Liturgia y culto en las iglesias de Palladio [PDF]

, 1996
Rodríguez G. de Ceballos, Alfonso
core   +1 more source

Architecture of Regionalism in the Age of Globalization: Peaks and Valleys in the Flat World. By Liane Lefaivre and Alexander Tzonis. Routledge, New York, 2011. Review. [PDF]

, 2012
Asselmeyer, Michael
core   +1 more source

What is the Appropriate Dose of Tolvaptan in ADPKD? [PDF]

Kidney Int Rep
Dahl NK, Torres VE.
europepmc   +1 more source

Concurrent Targeting of Vasopressin Receptor 2 and Somatostatin Receptors in Autosomal Dominant Polycystic Kidney Disease: A Promising Approach for Autosomal Dominant Polycystic Kidney Disease Treatment?

Clin J Am Soc Nephrol, 2023
Hogan MC, Masyuk TV.
europepmc   +1 more source

Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.

Clin J Am Soc Nephrol, 2022
Bae KT, Tao C, Feldman R, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Mrug M, Bennett WM, Harris PC, Srivastava A, Landsittel DP, Abebe KZ, CRISP and HALT PKD Consortium.   +16 more
europepmc   +1 more source